Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype

Cancer Genetics and Cytogenetics

Volumn 101, Issue 2, 1998, Pages 109-115

  Jarvis, Elizabeth M ^a   Kirk, Judy A ^a   Clarke, Christine L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; KI 67 ANTIGEN; PROGESTERONE;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIVISION; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PHENOTYPE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032032322     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00267-7     Document Type: Article

References (26)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding Wet al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem Get al. Identification of the breast cancer susceptibility gene BRCA2. Nat Genet. 378:1995;789-792.
3. Newman B, Austin MA, Lee M, King M-C Inheritance of human breast cancer. Evidence for autosomal dominant transmission in high risk families Proc Natl Acad Sci USA. 85:1988;3044-3048.
4. Claus EB, Risch N, Thompson WD Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 48:1991;232-242.
5. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 11:1995;198-200.
6. Jacquemier J, Eisinger F, Birnbaum D, Sobol H Histoprognostic grade in BRCA1-associated breast cancer. Lancet. 345:1995;1503.
7. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D, Sobol H Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res. 56:1996;471-474.
8. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage Cancer. 77:1996;697-709.
9. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 9:1995;444-450.
10. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C, Jensen RA Growth retardation and tumor inhibition by BRCA1. Nat Genet. 12:1996;298-302.
11. Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res. 55:1995;5063-5068.
12. Jensen RA, Thompson ME, Jetton TL, Szabo CI, van der Meer R, Helou B, Tronick SR, Page DL, King M-C, Holt JT BRCA1 is secreted and exhibits properties of a granin. Nat Genet. 12:1996;303-308.
13. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von-Hoff D, Osborne CK, Lee WH Aberrant subcellular localization of BRCA1 in breast cancer. Science. 270:1995;789-791.
14. Wilson CA, Payton MN, Pekar SK, Zhang K, Pacifici RE, Gudas JL, Thukral S, Calzone FJ, Reese DM, Slamon DI BRCA1 protein products. Antibody specificity Nat Genet. 13:1996;264-265.
15. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM Location of BRCA1 in human breast and ovarian cancer cells. Science. 272:1996;123-125.
16. Chen YM, Chen PL, Riley DJ, Lee WH, Allred DC, Osborne CK Location of BRCA1 in human breast and ovarian cancer cells - Response. Science. 272:1996;125-126.
17. Jensen RA, Thompson ME, Jetton TL, van der Meer R, Helou B, Arteaga CL, Page DL, Holt JT, Tronick SR, Gown AM, Skelly M, Ostermeyer B, Schieltz D, Szabo CI, King MC BRCA1 protein products. Antibody specificity... functional motifs... and secreted tumor suppressors - Reply Nat Genet. 13:1996;269-272.
18. Thakur S, Le H, Carroll B, Farid LM, Couch F, Wilson R, Weber BL Disparate localization of BRCA1 and an alternate splice form, gamma BRCA1. Proc Am Assoc Cancer Res. 37:1996;188.
19. Henderson IC Risk factors for breast cancer development. Cancer. 71(Suppl):1993;2127-2140.
20. McGuire WL, Chamness GC, Fuqua SAW Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 5:1991;1571-1577.
21. Chung M, Chang HR, Bland KI, Wanebo HJ Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 77:1996;97-103.
22. Gudas JM, Nguyen H, Li T, Cowan KH Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 55:1995;4561-4565.
23. NIH Consensus Conference (1991): Treatment of early-stage breast cancer. JAMA 265:391-395.
24. Linden MD, Torres FX, Kubus J, Zarbo RJ Clinical application of morphologic and immunohistochemical assessments of cell proliferation. Am J Clin Pathol. 97:1992;S4-S13.
25. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blamey RW, Nicholson RI Ki-67 immunostaining in primary breast cancer. Pathological and clinical associations Br J Cancer. 59:1989;943-947.
26. Wintzer H-O, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer. 67:1991;421-428.